Citigroup’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$287K Sell
14,072
-48,629
-78% -$993K ﹤0.01% 3189
2025
Q1
$1.26M Buy
62,701
+21,374
+52% +$428K ﹤0.01% 2410
2024
Q4
$1.1M Buy
41,327
+15,748
+62% +$420K ﹤0.01% 2539
2024
Q3
$730K Sell
25,579
-42,655
-63% -$1.22M ﹤0.01% 2769
2024
Q2
$1.49M Buy
68,234
+61,580
+925% +$1.34M ﹤0.01% 1969
2024
Q1
$147K Buy
6,654
+1,069
+19% +$23.7K ﹤0.01% 3408
2023
Q4
$121K Buy
5,585
+2,855
+105% +$61.6K ﹤0.01% 3385
2023
Q3
$46.1K Sell
2,730
-8,443
-76% -$143K ﹤0.01% 3477
2023
Q2
$153K Buy
11,173
+8,427
+307% +$116K ﹤0.01% 3359
2023
Q1
$62.4K Sell
2,746
-726
-21% -$16.5K ﹤0.01% 3566
2022
Q4
$81.7K Sell
3,472
-83,501
-96% -$1.97M ﹤0.01% 3413
2022
Q3
$2.27M Sell
86,973
-45,964
-35% -$1.2M ﹤0.01% 1521
2022
Q2
$2.92M Buy
132,937
+124,294
+1,438% +$2.73M ﹤0.01% 1357
2022
Q1
$388K Sell
8,643
-5,924
-41% -$266K ﹤0.01% 3006
2021
Q4
$624K Sell
14,567
-1,061
-7% -$45.5K ﹤0.01% 2915
2021
Q3
$1.04M Buy
15,628
+1,918
+14% +$128K ﹤0.01% 2363
2021
Q2
$1.01M Buy
13,710
+11,993
+698% +$879K ﹤0.01% 2611
2021
Q1
$118K Sell
1,717
-1,923
-53% -$132K ﹤0.01% 3626
2020
Q4
$244K Buy
3,640
+1,778
+95% +$119K ﹤0.01% 3121
2020
Q3
$96K Sell
1,862
-2,588
-58% -$133K ﹤0.01% 3161
2020
Q2
$168K Buy
4,450
+665
+18% +$25.1K ﹤0.01% 3170
2020
Q1
$113K Buy
3,785
+1,707
+82% +$51K ﹤0.01% 3224
2019
Q4
$71K Buy
2,078
+1,915
+1,175% +$65.4K ﹤0.01% 3742
2019
Q3
$3K Buy
+163
New +$3K ﹤0.01% 4887